PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
14-May-2025 Recipharm and PLG announce strategic partnership to accelerate development projects ProductLife Group
13-May-2025 SMC approval of BALVERSA®▼ (erdafitinib) helps pave the way for first licensed bladder cancer therapy that specifically targets fibroblast growth factor receptor (FGFR3) alterations Johnson & Johnson
12-May-2025 Pivotal supports expansion of enGene Clinical Trial for bladder cancer treatment into Europe PIVOTAL
09-May-2025 Vesper Bio achieves enrolment milestone in Phase Ib/IIa trial of lead candidate VES001 for frontotemporal dementia Vesper Bio
09-May-2025 iOnctura commences randomized Phase I/II study in non-small cell lung cancer iOnctura
07-May-2025 Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial Astrazeneca
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
01-May-2025 First patient enrolled in Phase 1 clinical trial of Akiram’s cancer drug candidate AKIR001 Akiram Therapeutics
01-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech
01-May-2025 argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) argenx
30-Apr-2025 Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025 Domain Therapeutics
24-Apr-2025 MAGIC-I study to revolutionise childhood cancer care in Ireland University College Dublin
24-Apr-2025 EMAS Pharma Rebrands as Evestia Clinical Evestia Clinical
15-Apr-2025 CluePoints’ Technology Named as Finalist in 2025 Citeline Awards CluePoints
15-Apr-2025 Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA HighTide Therapeutics, Inc.
15-Apr-2025 1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research 1ST Biotherapeutics
14-Apr-2025 New GDP Training with Certificate Pharma Lessons
11-Apr-2025 Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients Theriva Biologics
10-Apr-2025 Phastar Secures Finalist Spot at 2025 Citeline Awards Phastar
09-Apr-2025 Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System Microbot Medical